Impact of dynamic choice of delivery of oral preexposure prophylaxis during the postpartum period in South Africa

OBJECTIVE: Providing dynamic choice in preexposure prophylaxis (PrEP) delivery may improve PrEP use among postpartum women who discontinued PrEP in pregnancy. DESIGN: Randomized control trial. METHODS: Between April 2023 and May 2025, we enrolled postpartum women without HIV, >15 years old, previously enrolled in a PrEP trial in pregnancy who discontinued PrEP for >3 months, willing to restart PrEP. Participants were randomized 1 : 1 to PrEP-Choice (choice of rapid PrEP pick-up from clinic, community, or home-delivery, with HIV self-testing in any choice) vs. Enhanced-Counseling arm (clinic-based PrEP distribution and counseling with biofeedback from urine tenofovir testing). Primary outcome was PrEP use through 6 months defined as PrEP collection and use (self-reported) at baseline, 3 and 6 months using logistic regression via intention to treat analysis. Secondary outcomes included urine tenofovir-confirmed adherence at 6 months and PrEP use aligned with sex-activity. RESULTS: We enrolled 266 postpartum women who previously discontinued PrEP (n = 134 PrEP-Choice; n = 132 Enhanced-Counseling). Median age was 25-years [interquartile range (IQR) 21-30], median postpartum time was 4-months (IQR = 3-7), median time since last PrEP use was 2.9-months (IQR = 2.7-4.4). Within Choice-Arm, 49% selected rapid clinic pick-up (n = 65), 46% home delivery (n = 62), 5% community pick-up (n = 7); 45% (n = 59) switched delivery method at least once during trial. At 6 months, 42% in the Choice-Arm collected PrEP and reported use in past month vs. 38% in Enhanced-Counseling [odds ratio (OR) = 1.74; 95% confidence interval (CI) = 1.06-2.88]. Results were consistent in women reporting recent sex (OR = 1.74; 95% CI = 0.92-3.32). There was no difference by arm in objective PrEP use at 6 months: 15% had positive urine tenofovir tests in Choice vs. 13% in Enhanced-Counseling arm (OR = 1.20; 95% CI = 0.60-2.43). CONCLUSIONS: Offering dynamic choice in PrEP delivery increased continuation and reported PrEP use in postpartum women vs. biofeedback-enhanced counseling; although objectively-measured adherence was similar across arms.

Authors

Institutions

Publication Details

Journal
AIDS
Published
2026-11-17
DOI
https://doi.org/10.1097/qad.0000000000004646
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of dynamic choice of delivery of oral preexposure prophylaxis during the postpartum period in South Africa

Sumaya Dadan, Monica Gandhi, Kalisha Bheemraj, Thomas J. Coates et al.
AIDS
HIV/AIDS Research and Interventions
article

Impact of dynamic choice of delivery of oral preexposure prophylaxis during the postpartum period in South Africa

Sumaya Dadan, Monica Gandhi, Kalisha Bheemraj, Thomas J. Coates, Susan Cleary, Landon Myer, Kathryn L. Dovel, Dvora Joseph Davey
article en

Abstract

OBJECTIVE: Providing dynamic choice in preexposure prophylaxis (PrEP) delivery may improve PrEP use among postpartum women who discontinued PrEP in pregnancy. DESIGN: Randomized control trial. METHODS: Between April 2023 and May 2025, we enrolled postpartum women without HIV, >15 years old, previously enrolled in a PrEP trial in pregnancy who discontinued PrEP for >3 months, willing to restart PrEP. Participants were randomized 1 : 1 to PrEP-Choice (choice of rapid PrEP pick-up from clinic, community, or home-delivery, with HIV self-testing in any choice) vs. Enhanced-Counseling arm (clinic-based PrEP distribution and counseling with biofeedback from urine tenofovir testing). Primary outcome was PrEP use through 6 months defined as PrEP collection and use (self-reported) at baseline, 3 and 6 months using logistic regression via intention to treat analysis. Secondary outcomes included urine tenofovir-confirmed adherence at 6 months and PrEP use aligned with sex-activity. RESULTS: We enrolled 266 postpartum women who previously discontinued PrEP (n = 134 PrEP-Choice; n = 132 Enhanced-Counseling). Median age was 25-years [interquartile range (IQR) 21-30], median postpartum time was 4-months (IQR = 3-7), median time since last PrEP use was 2.9-months (IQR = 2.7-4.4). Within Choice-Arm, 49% selected rapid clinic pick-up (n = 65), 46% home delivery (n = 62), 5% community pick-up (n = 7); 45% (n = 59) switched delivery method at least once during trial. At 6 months, 42% in the Choice-Arm collected PrEP and reported use in past month vs. 38% in Enhanced-Counseling [odds ratio (OR) = 1.74; 95% confidence interval (CI) = 1.06-2.88]. Results were consistent in women reporting recent sex (OR = 1.74; 95% CI = 0.92-3.32). There was no difference by arm in objective PrEP use at 6 months: 15% had positive urine tenofovir tests in Choice vs. 13% in Enhanced-Counseling arm (OR = 1.20; 95% CI = 0.60-2.43). CONCLUSIONS: Offering dynamic choice in PrEP delivery increased continuation and reported PrEP use in postpartum women vs. biofeedback-enhanced counseling; although objectively-measured adherence was similar across arms.

AIDS
University of Cape Town (ZA), University of California, Los Angeles (US), University of California, San Francisco (US)
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon